Instil Bio, Inc. Profile Avatar - Palmy Investing

Instil Bio, Inc.

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline includ…

Biotechnology
US, Dallas [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of TIL's Analysis
CIK: 1789769 CUSIP: 45783C101 ISIN: US45783C2008 LEI: - UEI: -
Secondary Listings
TIL has no secondary listings inside our databases.